Advertisement
U.S. Markets closed

Neola Medical AB (publ) (NEOLA.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
2.4400-0.2000 (-7.58%)
At close: 12:35PM CEST
Currency in SEK

Valuation Measures4

Market Cap (intraday) 171.17M
Enterprise Value 142.06M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.32
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -11.81

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.7800
52 Week Low 31.1900
50-Day Moving Average 32.7380
200-Day Moving Average 32.2730

Share Statistics

Avg Vol (3 month) 320.52k
Avg Vol (10 day) 319.19k
Shares Outstanding 570.15M
Implied Shares Outstanding 6N/A
Float 832.21M
% Held by Insiders 167.68%
% Held by Institutions 111.26%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -85.34%
Operating Margin (ttm)-109.06%

Management Effectiveness

Return on Assets (ttm)-8.56%
Return on Equity (ttm)-13.81%

Income Statement

Revenue (ttm)11.1M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)6.40%
Gross Profit (ttm)N/A
EBITDA -8.83M
Net Income Avi to Common (ttm)-9.47M
Diluted EPS (ttm)-0.1600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)29.11M
Total Cash Per Share (mrq)0.41
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.47
Book Value Per Share (mrq)1.05

Cash Flow Statement

Operating Cash Flow (ttm)-7.18M
Levered Free Cash Flow (ttm)-17.92M